Spoken Alpha
Red Light Holland Corp.
Red Light Holland Corp is a Healthcare company operating in Drug Manufacturers - Specialty & Generic with a $16.1M market cap.
Most recent earnings call: Q3 FY24 on Mar 1, 2024.
Behavioral analysis
Disclosures
Extracted from Unknown source, 2026-06-21.
Transcripts
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
History
Reported quarters with consensus, surprise, and 1-day reaction context.
Spoken Alpha tracks TRUFF's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Misses consensus 10/10 quarters
SamplePeers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for TRUFF.
$ curl https://api.spokenalpha.com/v1/companies/TRUFFFAQ
Spoken Alpha indexes TRUFF's earnings call transcripts at https://spokenalpha.com/companies/TRUFF. Each call links to attributed speakers and parsed analyst Q&A. Red Light Holland Corp.'s own investor relations page is at https://redlight.co/investors.
Red Light Holland Corp. (TRUFF) held its most recent earnings call on 2024-03-01, covering fiscal Q3 2024.
Red Light Holland Corp. (TRUFF) operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
Repeated misses without a guidance reset suggest management is structurally optimistic relative to operating reality. Track whether next-quarter guidance is being benchmarked off the prior miss or the prior plan.
Missed in 4 of the last 4 quarters
SampleRecent misses matter more than long-window beat rate — the trailing 12 months drives the analyst model and the next-print bar.
| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2024 | $2.21 | $2.71 | -18.5% | +0.5% | +2.1% |
| Q4 FY2024 | $2.11 | $2.77 | -23.8% | +7.3% | +7.5% |
| Q3 FY2024 | $2.14 | $2.77 | -22.8% | +8.3% | +6.4% |
| Q2 FY2024 | $2.35 | $2.94 | -20.0% | +6.8% | +9.2% |
| Q1 FY2023 | $2.27 | $2.96 | -23.2% | +7.8% | +9.0% |
| Q4 FY2023 |
| $1.96 |
| $2.79 |
| -29.8% |
| +5.0% |
| +3.7% |
| Q3 FY2023 | $2.12 | $2.90 | -26.9% | -0.2% | +2.3% |
| Q2 FY2023 | $2.06 | $2.82 | -26.8% | -1.1% | -1.7% |
| Q1 FY2022 | $1.98 | $2.92 | -32.3% | +9.0% | +11.2% |
| Q4 FY2022 | $2.09 | $2.98 | -29.7% | +5.7% | +8.6% |